Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sangyub Kim

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Frontiers in Pharmacology|October 17, 2022
Decursinol-mediated antinociception and anti-allodynia in acute and neuropathic pain models in male mice: Tolerance and receptor profilingLaTaijah C Crawford, Sangyub Kim, Deepkamal Karelia, et al.
International Journal of Molecular Sciences|September 15, 2020
Colon Transcriptomics Reveals Sex-Dependent Metabolic Signatures in Response to 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine Treatment in C57BL/6N MiceJeong Hoon Pan, Cara Cicalo, Brandy Le, et al.
Molecular Cancer Therapeutics|September 1, 2018
Role of P53-Senescence Induction in Suppression of LNCaP Prostate Cancer Growth by Cardiotonic Compound BufalinYong Zhang, Yinhui Dong, Michael W Melkus, et al.
Food & Function|January 6, 2021
The role of microRNA-33 as a key regulator in hepatic lipogenesis signaling and a potential serological biomarker for NAFLD with excessive dietary fructose consumption in C57BL/6N miceJeong Hoon Pan, Hanvit Cha, Jingsi Tang, et al.
Nutrients|June 5, 2018
IDH2 Deficiency Aggravates Fructose-Induced NAFLD by Modulating Hepatic Fatty Acid Metabolism and Activating Inflammatory Signaling in Female MiceJeong Hoon Pan, Hoe-Sung Kim, Kaleigh Elizabeth Beane, et al.
Molecular Cancer Therapeutics|April 15, 2025
Azenosertib is a potent and selective WEE1 kinase inhibitor with broad antitumor activity across a range of solid tumorsJianhui Ma, Wen Liu, Jiali Li, et al.
NPJ Precision Oncology|January 4, 2025
Cyclin E1/CDK2 activation defines a key vulnerability to WEE1 kinase inhibition in gynecological cancersDaehwan Kim, Heekyung Chung, Wen Liu, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Frontiers in Pharmacology|October 17, 2022
Decursinol-mediated antinociception and anti-allodynia in acute and neuropathic pain models in male mice: Tolerance and receptor profilingLaTaijah C Crawford, Sangyub Kim, Deepkamal Karelia, et al.
International Journal of Molecular Sciences|September 15, 2020
Colon Transcriptomics Reveals Sex-Dependent Metabolic Signatures in Response to 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine Treatment in C57BL/6N MiceJeong Hoon Pan, Cara Cicalo, Brandy Le, et al.
Molecular Cancer Therapeutics|September 1, 2018
Role of P53-Senescence Induction in Suppression of LNCaP Prostate Cancer Growth by Cardiotonic Compound BufalinYong Zhang, Yinhui Dong, Michael W Melkus, et al.
Food & Function|January 6, 2021
The role of microRNA-33 as a key regulator in hepatic lipogenesis signaling and a potential serological biomarker for NAFLD with excessive dietary fructose consumption in C57BL/6N miceJeong Hoon Pan, Hanvit Cha, Jingsi Tang, et al.
Nutrients|June 5, 2018
IDH2 Deficiency Aggravates Fructose-Induced NAFLD by Modulating Hepatic Fatty Acid Metabolism and Activating Inflammatory Signaling in Female MiceJeong Hoon Pan, Hoe-Sung Kim, Kaleigh Elizabeth Beane, et al.
Molecular Cancer Therapeutics|April 15, 2025
Azenosertib is a potent and selective WEE1 kinase inhibitor with broad antitumor activity across a range of solid tumorsJianhui Ma, Wen Liu, Jiali Li, et al.
NPJ Precision Oncology|January 4, 2025
Cyclin E1/CDK2 activation defines a key vulnerability to WEE1 kinase inhibition in gynecological cancersDaehwan Kim, Heekyung Chung, Wen Liu, et al.
Pageof 4